您的位置: 首页 > 农业专利 > 详情页

PROTUTIJELA PROTIV CD40 I NJIHOVA UPOTREBA
专利权人:
Abbvie Inc.
发明人:
Benatuil, Lorenzo,Argiriadi, Maria A.,McRae, Bradford L.,Hsieh, Chung-Ming,Egan, David A.,Harlan, John E.,Judge, Russell A.,Wang, Rui,Kingsbury, Gillian A.
申请号:
HRP20200262
公开号:
HRP20200262T1
申请日:
2020.02.17
申请国别(地区):
HR
年份:
2020
代理人:
摘要:
The present invention encompasses antagonist anti-CD40 antibodies and antigen-binding portions thereof. Specifically, the invention relates to humanized anti-CD40 antibodies. In certain embodiments, antibodies of the invention neutralize human CD40 (hCD40) activity. Antibodies, or antibody portions, of the invention are useful for detecting CD40 and for inhibiting CD40 activity, e.g., in a human subject suffering from a disorder in which CD40 activity is detrimental.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充